Haemonetics Corporation
US ˙ NYSE ˙ US4050241003

SecurityHAE / Haemonetics Corporation
InstitutionAmalgamated Bank
Latest Disclosed Ownership20,145 shares
Latest Disclosed Value $ 1,135
Amalgamated Bank reports 1.97% increase in ownership of HAE / Haemonetics Corporation

On May 8, 2026 - Amalgamated Bank filed a 13F-HR form disclosing ownership of 20,145 shares of Haemonetics Corporation (US:HAE) valued at $1,135,372 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 19,755 shares of Haemonetics Corporation. This represents a change in shares of 1.97% during the quarter. The current value of the position is $1,327,153 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F HAEMONETICS CORP MASS COM 405024100 20,145 390 1.97 1 0.00 0.0087
2026-02-05 2025-12-31 13F HAEMONETICS CORP MASS COM 405024100 19,755 -1,386 -6.56 2 0.00 0.0114
2025-10-29 2025-09-30 13F HAEMONETICS CORP MASS COM 405024100 21,141 -927 -4.20 1 0.00 0.0074
2025-08-04 2025-06-30 13F HAEMONETICS CORP MASS COM 405024100 22,068 -334 -1.49 2 0.00 0.0127
2025-04-25 2025-03-31 13F HAEMONETICS CORP MASS COM 405024100 22,402 -578 -2.52 1 0.00 0.0122
2025-02-04 2024-12-31 13F HAEMONETICS CORP MASS COM 405024100 22,980 -485 -2.07 2 0.00 0.0147
2024-10-30 2024-09-30 13F HAEMONETICS CORP MASS COM 405024100 23,465 -1,185 -4.81 2 -50.00 0.0155
2024-08-12 2024-06-30 13F HAEMONETICS CORP MASS COM 405024100 24,650 -1,964 -7.38 2 0.00 0.0174
2024-04-23 2024-03-31 13F HAEMONETICS CORP MASS COM 405024100 26,614 -5,508 -17.15 2 0.00 0.0194
2024-02-06 2023-12-31 13F HAEMONETICS CORP MASS COM 405024100 32,122 -179 -0.55 3 0.00 0.0219
2023-11-08 2023-09-30 13F HAEMONETICS CORP MASS COM 405024100 32,301 -643 -1.95 3 0.00 0.0246
2023-08-11 2023-06-30 13F HAEMONETICS CORP MASS COM 405024100 32,944 -793 -2.35 3 0.00 0.0227
2023-05-02 2023-03-31 13F HAEMONETICS CORP MASS COM 405024100 33,737 -2,064 -5.77 3 0.00 0.0238
2023-02-10 2022-12-31 13F HAEMONETICS CORP MASS COM 405024100 35,801 226 0.64 3 -99.92 0.0251
2022-11-09 2022-09-30 13F HAEMONETICS CORP MASS COM 405024100 35,575 916 2.64 2,634 16.60 0.0254
2022-08-15 2022-06-30 13F HAEMONETICS CORP MASS COM 405024100 34,659 716 2.11 2,259 5.27 0.0211
2022-08-25 2022-03-31 13F/A-1 HAEMONETICS CORP MASS COM 405024100 33,943 -1,603 -4.51 2,146 13.85 0.0167
2022-06-30 2022-03-31 13F HAEMONETICS CORP MASS COM 405024100 33,943 -1,603 2,146 0.0170
2022-02-15 2021-12-31 13F/A-1 HAEMONETICS CORP MASS COM 405024100 35,546 219 0.62 1,885 -24.42 0.0139
2022-02-15 2021-12-31 13F HAEMONETICS CORP MASS COM 405024100 35,546 219 1,885 0.0139
2021-10-29 2021-09-30 13F HAEMONETICS CORP MASS COM 405024100 35,327 -3,793 -9.70 2,494 -4.33 0.0211
2021-08-16 2021-06-30 13F HAEMONETICS CORP MASS COM 405024100 39,120 29,531 307.97 2,607 145.02 0.0209
2021-05-13 2021-03-31 13F HAEMONETICS CORP MASS COM 405024100 9,589 -670 -6.53 1,064 -12.64 0.0399
2021-02-12 2020-12-31 13F HAEMONETICS CORP MASS COM 405024100 10,259 36 0.35 1,218 36.55 0.0462
2020-10-30 2020-09-30 13F HAEMONETICS CORP MASS COM 405024100 10,223 -283 -2.69 892 -5.21 0.0388
2020-08-10 2020-06-30 13F HAEMONETICS CORP MASS COM 405024100 10,506 889 9.24 941 -1.77 0.0435
2020-05-13 2020-03-31 13F HAEMONETICS CORP MASS COM 405024100 9,617 -530 -5.22 958 -17.84 0.0234
2020-02-13 2019-12-31 13F HAEMONETICS CORP MASS COM 405024100 10,147 619 6.50 1,166 -3.00 0.0215
2019-11-13 2019-09-30 13F HAEMONETICS CORP MASS COM 405024100 9,528 -146 -1.51 1,202 3.26 0.0253
2019-08-14 2019-06-30 13F HAEMONETICS CORP MASS COM 405024100 9,674 1,393 16.82 1,164 60.77 0.0272
2019-05-15 2019-03-31 13F HAEMONETICS CORP MASS COM 405024100 8,281 164 2.02 724 -10.84 0.0175
2019-02-15 2018-12-31 13F HAEMONETICS CORP MASS COM 405024100 8,117 4,535 126.61 812 98.05 0.0230
2018-11-14 2018-09-30 13F HAEMONETICS CORP MASS COM 405024100 3,582 -5,175 -59.10 410 -47.77 0.0101
2018-07-18 2018-06-30 13F HAEMONETICS CORP MASS COM 405024100 8,757 1,046 13.57 785 39.18 0.0192
2018-05-22 2018-03-31 13F HAEMONETICS CORP MASS COM 405024100 7,711 -41 -0.53 564 25.33 0.0150
2018-02-13 2017-12-31 13F HAEMONETICS CORP MASS COM 405024100 7,752 580 8.09 450 39.75 0.0122
2017-11-09 2017-09-30 13F HAEMONETICS CORP MASS COM 405024100 7,172 -150 -2.05 322 11.42 0.0100
2017-08-10 2017-06-30 13F HAEMONETICS CORP MASS COM 405024100 7,322 392 5.66 289 2.85 0.0095
2017-05-12 2017-03-31 13F HAEMONETICS CORP MASS COM 405024100 6,930 7 0.10 281 1.08 0.0140
2017-02-14 2016-12-31 13F HAEMONETICS CORP MASS COM 405024100 6,923 822 13.47 278 25.79 0.0126
2016-11-15 2016-09-30 13F/A-1 HAEMONETICS CORP MASS COM 405024100 6,101 13 0.21 221 0.91 0.0128
2016-08-16 2016-06-30 13F HAEMONETICS CORP MASS COM 405024100 6,088 6,088 0.00 219 0.0127
2015-11-04 2015-09-30 13F HAEMONETICS CORP MASS COM 405024100 0 -5,341 -100.00 0 -100.00
2015-07-10 2015-06-30 13F HAEMONETICS CORP MASS COM 405024100 5,341 46 0.87 221 -0.90 0.0217
2014-02-13 2013-12-31 13F HAEMONETICS CORP MASS COM 405024100 5,295 5,295 223 0.0379
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.